© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Tactile Systems Technology, Inc. (TCMD) stock declined over -1.39%, trading at $27.03 on NASDAQ, down from the previous close of $27.41. The stock opened at $27.09, fluctuating between $26.69 and $27.59 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 18, 2026 | 27.33 | 27.59 | 26.69 | 27.03 | 250.51K |
| Mar 17, 2026 | 27.33 | 27.99 | 27.16 | 27.41 | 195.77K |
| Mar 16, 2026 | 27.19 | 27.87 | 26.94 | 27.30 | 155.62K |
| Mar 13, 2026 | 27.65 | 27.95 | 26.30 | 26.93 | 154.29K |
| Mar 12, 2026 | 27.31 | 27.86 | 27.06 | 27.57 | 410.76K |
| Mar 11, 2026 | 27.83 | 28.10 | 27.08 | 27.86 | 211.21K |
| Mar 10, 2026 | 28.62 | 29.01 | 28.08 | 28.11 | 288.63K |
| Mar 09, 2026 | 28.34 | 29.06 | 27.19 | 28.96 | 393.23K |
| Mar 06, 2026 | 28.89 | 29.06 | 28.35 | 28.81 | 173.46K |
| Mar 03, 2026 | 28.89 | 29.92 | 28.47 | 29.86 | 199.56K |
| Mar 02, 2026 | 28.93 | 29.65 | 28.49 | 29.29 | 328.66K |
| Feb 27, 2026 | 29.80 | 29.93 | 28.92 | 29.29 | 283.22K |
| Feb 26, 2026 | 29.74 | 30.06 | 29.00 | 29.91 | 306.6K |
| Feb 25, 2026 | 28.47 | 29.69 | 28.23 | 29.61 | 347.01K |
| Feb 24, 2026 | 28.64 | 29.49 | 28.45 | 28.65 | 352.9K |
| Feb 23, 2026 | 28.43 | 28.81 | 27.56 | 28.66 | 521.68K |
| Feb 20, 2026 | 28.01 | 29.16 | 27.74 | 28.72 | 633.84K |
| Feb 19, 2026 | 33.00 | 33.00 | 28.17 | 28.25 | 1.08M |
| Feb 18, 2026 | 35.74 | 37.77 | 32.82 | 33.05 | 1.83M |
| Feb 17, 2026 | 26.57 | 28.27 | 26.57 | 28.05 | 606.89K |
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
| Employees | 1037 |
| Beta | 0.96 |
| Sales or Revenue | $274.42M |
| 5Y Sales Change% | 0.611% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |